| CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
JAK1 |
|
0.295 |
Evidence |
|
| CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
CD2AP |
CD2AP: CD2-associated protein |
0.295 |
Evidence |
|
| CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.295 |
Evidence |
|
| CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.295 |
Evidence |
|
| LRP1 |
LRP1, A2MR, APR: Prolow-density lipoprotein receptor-related protein 1 precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.295 |
Evidence |
|
| CD69 |
CD69: Early activation antigen CD69 |
FUBP1 |
IPI00375441 |
0.295 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
| CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
SPTAN1 |
IPI00413728 |
0.295 |
Evidence |
|
| RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
0.295 |
Evidence |
|
| RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.295 |
Evidence |
|
| HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
MPZL1 |
MPZL1, PZR, UNQ849/PRO1787: Myelin protein zero-like protein 1 precursor |
0.295 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.295 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
LASP1 |
LASP1, MLN50: LIM and SH3 domain protein 1 |
0.295 |
Evidence |
|
| RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
FUBP1 |
IPI00375441 |
0.295 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.295 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
CRLF3 |
IPI00295387 |
0.295 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.295 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
0.295 |
Evidence |
|
| GNB2L1 |
Lung cancer oncogene 7 |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.295 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.295 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
CD69 |
CD69: Early activation antigen CD69 |
0.295 |
Evidence |
|
| RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.295 |
Evidence |
|
| PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
LILRB1 |
IPI00385703 |
0.295 |
Evidence |
|
| PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.295 |
Evidence |
|